Spinal Elements Announces Relaunch of Luna XD and Orbit Systems: Dr. Richard Fessler Performs 1st Minimally-invasive Transforaminal Lumbar Interbody Fusion

March 3, 2021

Spinal Elements announced the relaunch and first clinical use of the Luna® XD multi-expandable lumbar interbody fusion device and Orbit® articulating discectomy system.

Spinal Elements notes a minimally-invasive transforaminal lumbar interbody fusion (TLIF) surgery was performed with the devices by Richard G. Fessler, M.D., Ph.D of Rush University Medical Group, Chicago, IL.

“I am very pleased to be using both Orbit and Luna XD in my MIS TLIF procedures again,” stated Dr. Fessler.  “Orbit is a best-in-class system that allows me to provide a safe and more thorough discectomy while Luna XD’s multi-expandable profile and footprint provides a large area for bone grafting and controlled restoration of disc height and lordosis, contributing to the consistency and positive clinical outcomes of my TLIF procedures.  I look forward to sharing these results in an upcoming peer-reviewed publication.”

The Orbit system consists of articulating and rotating discectomy instrumentation that uses a minimal, posterior incision and/or MIS tubular approach to achieve efficient disruption and removal of disc tissue while preparing the endplates for fusion.  The novel articulating rotary design allows the instrumentation’s working end to evacuate the full area of the disc necessary for implantation of the Luna XD circular device.

The Luna XD system allows an ALIF-sized, circular implant to be surgically delivered to the intervertebral space through a posterior, minimally-invasive access point.  Once inserted, the Luna XD implant first expands horizontally to cover the disc footprint, creating a stable foundation.  Then the implant expands vertically up to 16mm to restore disc height.  Furthermore, the device includes  up to 12° of lordosis to aid in the restoration of sagittal alignment.

Luna XD and Orbit have been integrated as the newest technologies within Spinal Elements’ MIS Ultra™ platform of products and procedural solutions.  At the time of acquisition, the company announced its goal of a relaunch of the technology by the second quarter of 2021 and through the efficiency of its integration team has been able to deliver the goal on a faster timeline.

Jason Blain, CEO of Spinal Elements, stated, “The acquisition and integration of the Luna XD and Orbit technologies into the Spinal Elements MIS Ultra portfolio allows Spinal Elements to continue to deliver innovative and clinically-differentiated technologies to surgeons like Dr. Fessler and their patients.  Both of these technologies further our goal of being a driving force that fundamentally changes the way spine surgeons approach and operate in minimally-invasive spinal procedures.  I am proud of the execution success our team showed in quickly returning these technologies to market.”

Spinal Elements acquired the Luna XD and Orbit systems in December 2020 along with the assets of the former Benvenue Medical.  The company anticipates a resurgence in the surgical use of both products in posterior lumbar fusion spinal procedures.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version